Skip to main content

Military Health System

New Travis AFB patient transport system supports COVID fight

Image of Soldiers in masks pushing a piece of equipment. U.S. Airmen assigned to the 60th Aerial Port and 21st Airlift Squadrons push a Negatively Pressurized Conex into a C-17 Globemaster III at Travis Air Force Base, California, Aug. 5, 2020. The NPC is certified for use on the C-17, and testing and certification is underway for use on the C-5M Super Galaxy. (U.S. Air Force photo by Lan Kim)

Recommended Content:

Coronavirus & the MHS Response

TRAVIS AIR FORCE BASE, California -- Travis Air Force Base gained a new isolated containment chamber Aug. 5 that can safely transport up to 24 walking patients, or eight patients on a stretcher with infectious diseases, such as the novel coronavirus, aboard an aircraft.

The unit, called a Negatively Pressurized Conex, is the third of its kind, with the first two already at Joint Base Charleston, South Carolina, and Ramstein Air Base, Germany.

Earlier this year, the Department of Defense and Air Force developed and procured the NPC in less than 30 days in response to a U.S. Transportation Joint Urgent Operational Need to transport COVID-19 patients.

Upon its arrival to Travis AFB, an NPC program manager and deputy program manager from the Air Force Life Cycle Management Center’s Air Force Chemical, Biological, Radiological, and Nuclear Defense Systems Branch, or AFLCMC/WNU, inspected the conex. They also oversaw transfer of the NPC from Delta Flight Products in Atlanta, Georgia, where it was manufactured, to the cargo bay of a Travis AFB C-17 Globemaster III staged to support alert aeromedical evacuation missions.

“We were with the NPC as it was being produced,” said U.S. Air Force Capt. Alexis Todaro, AFLCMC/WNU NPC program manager. “We did both inspections, as well as functional checks, to make sure the asset was performing and everything was included as contracted. We followed it to Travis and made sure the offload went smoothly. Next, we’ll work with the aeromedical team that is here training and go over a few of the features they may or may not be familiar with.”

The first operational use of an NPC took place July 1, moving 12 patients from the U.S. Central Command area of responsibility to Ramstein AB. Since then, it has undergone several iterations of testing and user feedback, Todaro said.

Compared to its predecessors, the NPC that arrived at Travis has notably bigger doors and windows to allow for better visual communication, as well as seats with increased safety factor ratings, Todaro said.

The new system will amplify Travis AFB’s current infectious disease patient transport capabilities, which consist of eight Transport Isolation Systems.

The TIS, which has been the primary means for the Air Force to transport COVID-19 patients since the onset of the coronavirus pandemic, is only capable of transporting up to four patients.

The NPC has a greater capacity of transporting up to 30 aircraft passengers and multiple configurations to accommodate combinations of ambulatory and litter patients, as dictated by the mission, said 1st Lt. Donald Wiegner, AFLCMC/WNU NPC deputy program manager.

Due to its capacity, the NPC will become the primary transport option of COVID-19 patients within the U.S. Indo-Pacific Command area of responsibility, Todaro said.

“The Indo-Pacific fight against COVID-19 hot spots is constantly changing throughout AORs,” said Wiegner. “With the limited NPC assets available at this time, it is a strategic advantage to posture at Travis AFB as a central logistical hub for NPCs to run missions throughout the Indo-Pacific as needed to evacuate soldiers, sailors, Marines, and airmen so they can get the medical care they need.”

As of Aug. 7, AMC’s NPC and TIS bio-containment units have transported 190 patients total on 30 separate aeromedical evacuation missions since the first operational use of the TIS April 10.

You also may be interested in...

Genome Sequencing Assists Research at Naval Health Research Center

Article
1/24/2023
Lab technicians doing genome research

Learn how unique samples from naval vessels, US-Mexico border populations, and DOD beneficiaries aided in the Naval Health Research Center’s sequencing efforts.

Recommended Content:

Research & Innovation | Coronavirus & the MHS Response | Coronavirus

U.S. Military HIV Research Lends Lessons Learned to COVID-19

Article
1/19/2023
Gloved hands working in laboratory

The U.S. military has engaged in HIV research for three decades, contributing critical lessons learned, knowledge, and expertise during the COVID-19 research and vaccine development effort.

Recommended Content:

Coronavirus & the MHS Response | DOD HIV/AIDS Prevention Program | Research & Innovation | Coronavirus

Naval Medical Research Center Uses Genome Sequencing for Variants

Article
1/12/2023
Military personnel pose for a group photo

NMRC’s efforts provided important support for sequencing and viral isolation to the Department of Defense and Military Health System.

Recommended Content:

Research & Innovation | Coronavirus & the MHS Response | Coronavirus

USAMRIID Focuses on Genome Sequencing to Detect Variants

Article
1/5/2023
Military medical personnel in laboratory

A connected family of laboratories across the MHS allows a more rapid response to the outbreak.

Recommended Content:

Research & Innovation | Coronavirus & the MHS Response | Coronavirus

Whole Genome Sequencing at Tripler Army Medical Center

Article
12/29/2022
Dr. Keith Fong reviews data with other lab technicians

The third installment in a 6-part series highlighting the efforts of the Military Health System laboratories and the technicians who worked to identify COVID-19 variants using special sequencing technology.

Recommended Content:

Coronavirus & the MHS Response | Research & Innovation | Coronavirus

Walter Reed Army Institute of Research Implements SARS-CoV-2 Genome Sequencing

Article
12/23/2022
Military medical personnel in laboratory

This is the second article in a 6-part series that highlights the work of technicians and scientists in Military Health System laboratories who worked to identify COVID-19 variants using special sequencing technology.

Recommended Content:

Global Health Engagement | Coronavirus & the MHS Response | Research & Innovation

Protect Yourself With Respiratory Illnesses on the Rise

Article Around MHS
12/19/2022
Military medical personnel administering vaccine

"Tis the season, and respiratory illnesses are on the rise. Learn critical health guidance about the viral triple threat of COVID-19, influenza, and the common cold, and the commonsense steps you can take to protect yourself and your family.

Recommended Content:

Coronavirus & the MHS Response | Children's Health | Medical and Dental Preventive Care Fitness | Immunization Tool Kit | Influenza, Northern Hemisphere | Immunization Healthcare Division

Military Labs Use Whole Genome Sequencing of COVID-19 Variants

Article
12/16/2022
Lab technician at work

The first in a 6-part series highlighting the work of technicians and scientists working in support of the MHS who identified COVID-19 variants using special sequencing technology.

Recommended Content:

Research & Innovation | Coronavirus & the MHS Response | Coronavirus

DOD Reduces Health Care Waste by Reusing Crutches

Article
12/15/2022
Military personnel using crutches

When military facilities faced a national shortage of an essential mobility aid, they launched a grassroots initiative that not only ensured patient care, but also created a new waste reduction model within the DHA.

Recommended Content:

Warrior Care | Coronavirus & the MHS Response

Naval Medical Research Center Joint Study with Mount Sinai Uncovers Differences in COVID-19 Immune Response between the Sexes

Article Around MHS
12/5/2022
Amanda Cherry, research assistant, performing diagnostic testing at NMRC

A collaborative study between researchers at Naval Medical Research Center and the Icahn School of Medicine at Mount Sinai, and Princeton University has highlighted immune response differences in the coronavirus infection responses between male and female patients.

Recommended Content:

Medical Research and Development | Coronavirus & the MHS Response | Coronavirus

Collaborating In the ER: Reservists Assist, Learn in Community Hospitals

Article Around MHS
10/20/2022
Military medical personnel in medical training session

In the early days of the COVID-19 pandemic–when there were no vaccines, a shortage of health care workers, and hospitals were beyond capacity– the U.S. health care system needed help. Here's one of many ways the Department of Defense answered the call.

Recommended Content:

Coronavirus & the MHS Response

Time to Get Your Flu Shot and Your COVID-19 Booster, Too

Article
10/14/2022
Senior MHS officials and medics from the Pentagon stand together Oct. 13 after receiving their flu shots and bivalent COVID-19 boosters.."

It's flu shot time. Get your COVID-19 booster at the same time.

Recommended Content:

Coronavirus & the MHS Response | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine | Seasonal Influenza Vaccine Toolkit | Immunizations | Coronavirus

Prevent the Spread of Influenza and COVID-19 Viruses Within Your Community

Article
10/11/2022
A person getting an injection on their arm.

As families return from summer vacation and students return to school, the influenza (flu) season is approaching while the COVID-19 pandemic is still on-going.

Recommended Content:

Coronavirus & the MHS Response | COVID-19 Vaccine Efforts | Immunizations | Coronavirus and the COVID-19 Vaccine | Seasonal Influenza Vaccine Toolkit

Consolidated Department of Defense Coronavirus Disease 2019 Force Health Protection Guidance

Policy

Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.

COVID-19 Moderna and Pfizer Vaccines

Publication
8/17/2022

Moderna and Pfizer mRNA vaccines are available. Moderna includes two doses, 28 days apart. Pfizer includes two doses, 21 days apart. Remember to mark your calendar and schedule time for your second dose

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | Types of COVID-19 Vaccines | Coronavirus & the MHS Response
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 23
Refine your search
Last Updated: August 15, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery